Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Clinical diagnosis of breast cancer

• Age ≥50 years old

• the treatment plan discussed by MDT includes surgery and chemotherapy

• can walk on their own (with the assistance of walking aids)

Locations
Other Locations
China
Ju Qiu
RECRUITING
Chongqing
Contact Information
Primary
ju qiu, Bachelor.
qiujuchongyi@163.com
18523569369
Backup
lin zeng
Time Frame
Start Date: 2023-08-12
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 500
Treatments
To select a suitable frailty screening scale for future frailty screening of breast cancer patients
Only basic inquiries and measurements are performed on the patient, without any intervention.
Related Therapeutic Areas
Sponsors
Collaborators: Ministry of Education, China
Leads: Ju Qiu

This content was sourced from clinicaltrials.gov